VIRGINIA HARDAWAY: Open Payments
NPI 1134570856 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,015 in 49 payments from 12 companies in 2025. Trend: 2023 $1,522 · 2024 $3,105 · 2025 $1,015
Food & beverage: $1,015
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 8 | $214 |
| Novartis Pharmaceuticals Corporation | 13 | $186 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 14 | $168 |
| Abbott Laboratories | 2 | $146 |
| Edwards Lifesciences Corporation | 1 | $100 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $51 |
| Alnylam Pharmaceuticals Inc. | 1 | $39 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
| PFIZER INC. | 2 | $28 |
| Medtronic, Inc. | 1 | $17 |
Products named: VERQUVO, LifeVest, LEQVIO, JOT DX, SAPIEN 3 Ultra RESILIA, JARDIANCE, AMVUTTRA, CAMZYOS.
Industry payments across TX — which companies pay providers there.
